The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.
|
|
NICE says yes to blood disorder treatment in final guidance
NICE has recommended eltrombopag (Revolade, GlaxoSmithKline) as an option for treating some adults with the bleeding disorder chronic immune (idiopathic) thrombocytopenic purpurai in final guidance.
July 24, 2013
|
|
NICE gives green light to treatment for wet AMD in final guidance
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending aflibercept solution for injection as an option for treating wet age-related macular degeneration (AMD).
July 24, 2013
|
|
NICE consults on belimumab for systemic lupus erythematosus
NICE, the health and social care guidance body, has today (24 July) opened a second public consultation on the use of belimumab (Benlysta) for treating systemic lupus erythematosus.
July 24, 2013
|
|
NICE says people with severe varicose veins should be offered heat energy and laser treatment as an alternative to surgery, saving time and money for the NHS
NICE has recommended that some people with varicose veins, such as those causing pain and ulcers, should be offered alternatives to surgery, known as endothermal ablation, heat energy treatment of the wall of the vein (radiofrequency or laser treatment), which are less invasive than surgery with a much speedier recovery time.
July 24, 2013
|
|
NICE consults on treatment for rare autoimmune disease and asks for further information from the manufacturer
NICE has today (23 July) published draft guidance on rituximab (MabThera, Roche Products).
July 23, 2013
|
|
NICE Citizens Council publishes final report on development of social care guidance
The Citizens Council, which advises the National Institute for Health and Care Excellence, has published its final report on factors that it believes should be considered when NICE develops social care guidance.
July 19, 2013
|
|
NICE draft guidance recommends drugs to treat chronic hepatitis C in children and young people
In draft guidance for consultation NICE recommends the use of peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people.
July 18, 2013
|
|
NICE guidance supports use of a device to visualise the airway in emergencies and improve patient safety
NICE today (17 July) publishes guidance supporting the NHS using a device to help health professionals keep patients? airways open when unexpected problems occur during procedures.
July 17, 2013
|
|
NICE guidance supports new device for assessing a pregnancy complication which affects thousands of women
NICE guidance published today (17 July) supports the use of a device to assess the potentially serious complication of unexplained vaginal wetness in pregnancy. The wetness could simply be leaking urine which is not a cause for immediate concern, or it could be leaking amniotic fluid, which would indicate that the fetal membranes had ruptured, with the potential for infection to occur.
July 17, 2013
|
|
NICE consults on newly updated draft recommendations for diagnosing and treating prostate cancer
The National Institute for Health and Care Excellence (NICE) is currently updating its clinical guideline on the diagnosis and treatment prostate cancer. As part of this process, draft recommendations have been published on the NICE website today for public consultation.
July 16, 2013
|
This page was last updated: 24 July 2013